טוען...
New Roadmaps for Non-muscle-invasive Bladder Cancer With Unfavorable Prognosis
About 70% of bladder cancers (BCs) are diagnosed as non-muscle-invasive BCs (NMIBCs), while the remaining are muscle-invasive BCs (MIBCs). The European Association of Urology (EAU) guidelines stratify NMIBCs into low, intermediate, and high risk for treatment options. Low-risk NMIBCs undergo only th...
שמור ב:
| הוצא לאור ב: | Front Chem |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7413024/ https://ncbi.nlm.nih.gov/pubmed/32850635 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fchem.2020.00600 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|